SS
IMVT icon

Steve Schonfeld’s Immunovant IMVT Stock Holding History

Steve Schonfeld’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33,553
Closed -$833K – 2792
2026
Q1 		$833K Buy
+33,553
New +$869K 0.01% 1177
2025
Q4 		– Sell
-115,750
Closed -$1.87M – 2281
2025
Q3 		$1.87M Buy
+115,750
New +$1.87M 0.01% 1069
2024
Q4 		– Sell
-98,274
Closed -$2.8M – 2189
2024
Q3 		$2.8M Buy
98,274
+76,047
+342% +$2.24M 0.02% 749
2024
Q2 		$587K Buy
+22,227
New +$632K ﹤0.01% 1423
2023
Q3 		– Sell
-55,475
Closed -$1.05M – 2002
2023
Q2 		$1.05M Buy
55,475
+17,813
+47% +$332K 0.01% 948
2023
Q1 		$584K Sell
37,662
-64,123
-63% -$1.11M 0.01% 1123
2022
Q4 		$1.81M Sell
101,785
-15,639
-13% -$197K 0.02% 863
2022
Q3 		$656K Buy
+117,424
New +$574K 0.01% 1553
2021
Q4 		– Sell
-24,400
Closed -$212K – 2325
2021
Q3 		$212K Sell
24,400
-25,600
-51% -$231K ﹤0.01% 1734
2021
Q2 		$529K Sell
50,000
-5,303
-10% -$74K 0.01% 1163
2021
Q1 		$887K Buy
55,303
+36,674
+197% +$967K 0.01% 945
2020
Q4 		$860K Sell
18,629
-26,283
-59% -$1.22M 0.01% 862
2020
Q3 		$1.58M Buy
44,912
+10,512
+31% +$316K 0.03% 577
2020
Q2 		$837K Buy
+34,400
New +$737K 0.02% 659
2020
Q1 		– Sell
-85,000
Closed -$1.35M – 1319
2019
Q4 		$1.35M Buy
+85,000
New +$952K 0.03% 424

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Steve Schonfeld's IMVT Position: Q2 2026 in Review

Steve Schonfeld sold out of Immunovant (IMVT) in Q2 2026, closing a stake of 33,553 shares — an estimated $833K sold.

Steve Schonfeld first reported a position in IMVT in Q4 2019 and held it in 15 quarters. The position peaked at $2.8M in Q3 2024. 224 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Steve Schonfeld reported no remaining Immunovant position as of Q2 2026 after selling out during the quarter.
  • Steve Schonfeld sold 33,553 Immunovant shares in Q2 2026, an estimated $833K.
  • Steve Schonfeld first reported a position in Immunovant in Q4 2019 and held it in 15 quarters.
  • Steve Schonfeld's Immunovant position peaked at $2.8M in Q3 2024.
  • 224 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.